Compare INMD & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMD | TRTX |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.2M | 708.3M |
| IPO Year | 2019 | 2017 |
| Metric | INMD | TRTX |
|---|---|---|
| Price | $14.52 | $9.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $17.00 | $10.75 |
| AVG Volume (30 Days) | ★ 581.0K | 545.5K |
| Earning Date | 02-03-2026 | 10-28-2025 |
| Dividend Yield | N/A | ★ 10.48% |
| EPS Growth | ★ 20.42 | N/A |
| EPS | ★ 2.21 | 0.65 |
| Revenue | ★ $364,494,000.00 | $138,590,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.76 | $8.19 |
| P/E Ratio | ★ $6.56 | $14.14 |
| Revenue Growth | N/A | ★ 4.13 |
| 52 Week Low | $13.14 | $6.47 |
| 52 Week High | $19.78 | $9.85 |
| Indicator | INMD | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 59.61 |
| Support Level | $14.24 | $9.01 |
| Resistance Level | $14.58 | $9.17 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 91.41 | 87.00 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.